Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • DTAB Recommends Registered Pharmacist as Competent Person for Wholesale Drug Licences
    23 September 2026

    DTAB Recommends Registered Pharmacist as Competent Person for Wholesale Drug Licences

    The Drugs Technical Advisory Board (DTAB) has once again recommended that a Registered Pharmacist should be the required qualification for a competent person for wholesale drug licences in Form 20B and Form 21B under Rule 64 of the Drugs Rules, 1945.
  • Union Health Ministry Issues Advisory on Stem Cell Therapy; Use for Autism Restricted to Approved Clinical Trials
    23 September 2026
    Union Health Ministry Issues Advisory on Stem Cell Therapy; Use for Autism Restricted to Approved Clinical Trials

    The Ministry of Health and Family Welfare has issued an advisory to States and Union Territories regarding the regulation of stem cell therapy, reiterating that stem cell treatments can be offered as standard clinical care only for approved disease conditions and indications. The advisory was issued on September 16, 2026, in the context of the Supreme Court judgment dated January 30, 2026, in Yash Charitable Trust & Ors. v. Union of India & Ors.

  • CDSCO Warns Against Indiscriminate Use of Painkillers and Antibiotics Over Kidney Risks
    23 September 2026
    CDSCO Warns Against Indiscriminate Use of Painkillers and Antibiotics Over Kidney Risks
    The Central Drugs Standard Control Organisation (CDSCO), under the Directorate General of Health Services, Government of India, has issued a circular advising against the indiscriminate use of non-steroidal anti-inflammatory drugs (NSAIDs), commonly used as painkillers, and antibiotics.
  • Fermented Stevia Extract Shows Potential Against Pancreatic Cancer Cells, Study Finds
    21 September 2026
    Fermented Stevia Extract Shows Potential Against Pancreatic Cancer Cells, Study Finds

    A research team from Hiroshima University has reported that stevia leaf extract fermented with the plant-derived bacterium Lactobacillus plantarum SN13T demonstrated enhanced anticancer activity against pancreatic cancer cells in laboratory experiments.

    The study, published in the International Journal of Molecular Sciences, investigated whether fermentation could improve the biological activity of stevia leaf extract and identified chlorogenic acid methyl ester (CAME) as an important compound associated with the observed effects.

  • Takeda and Dr. Reddy’s Partner to Promote and Distribute QDENGA® in India’s Private Pediatric and Adult Market
    18 September 2026
    Takeda and Dr. Reddy’s Partner to Promote and Distribute QDENGA® in India’s Private Pediatric and Adult Market
    QDENGA®, across India’s private market for pediatric and adult vaccination in India. Subject to completion of applicable processes with local authorities, the vaccine is anticipated to become available in the first half of 2027.
  • FDA Expands Finerenone Approval to Type 1 Diabetes-Linked Kidney Disease
    18 September 2026
    FDA Expands Finerenone Approval to Type 1 Diabetes-Linked Kidney Disease
    The U.S. Food and Drug Administration (FDA) has approved Kerendia (finerenone) for a new indication in adults with chronic kidney disease (CKD) associated with type 1 diabetes (T1D). Bayer announced it as the first FDA-approved treatment option in more than 30 years for adults with CKD associated with type 1 diabetes
  • FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
    18 September 2026
    FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
    Sanfilippo syndrome type A is a rare inherited disorder that primarily affects the brain and nervous system. Children with the condition can experience progressive loss of cognitive, language and other developmental abilities. Before this approval, there was no FDA-approved treatment specifically designed to address the underlying cause of MPS IIIA
  • India, China and Pakistan Named in US 2027 Major Drug Transit and Production List
    17 September 2026
    India, China and Pakistan Named in US 2027 Major Drug Transit and Production List

    The United States has included India, China and Pakistan among 23 countries designated as major drug transit or major illicit drug-producing countries for fiscal year 2027. The designation was submitted to the U.S. Congress on September 15, 2026, as part of the annual U.S. “Major’s List,” which identifies countries considered significant sources or transit points for illicit drugs entering the United States.

  • Dr. Reddy’s Expands Lenacapavir Partnership With Gilead for Future HIV Prevention Access
    17 September 2026
    Dr. Reddy’s Expands Lenacapavir Partnership With Gilead for Future HIV Prevention Access

    Dr. Reddy’s Laboratories has expanded its collaboration with Gilead Sciences through a royalty-free, non-exclusive voluntary licensing agreement covering investigational once-yearly lenacapavir for HIV prevention. The agreement builds on the companies’ existing 2024 licensing arrangement for lenacapavir and is intended to support future manufacturing readiness, technology transfer and supply planning in licensed territories.

  • Vera Therapeutics Reports Sustained Kidney Function in Phase 3 Trial of TRUTAKNA for IgA Nephropathy
    17 September 2026
    Vera Therapeutics Reports Sustained Kidney Function in Phase 3 Trial of TRUTAKNA for IgA Nephropathy

    Vera Therapeutics has announced final efficacy results from the Phase 3 ORIGIN 3 study of TRUTAKNA™ (atacicept-vymj), reporting sustained stabilization of kidney function and a reduced risk of kidney disease progression in adults with primary IgA nephropathy (IgAN). The final analysis included 428 patients with primary IgAN who were considered at risk of disease progression.

Subscribe to Pharma News